Working… Menu

Pan Tumor Nivolumab Rollover Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03899155
Recruitment Status : Recruiting
First Posted : April 2, 2019
Last Update Posted : December 6, 2021
Information provided by (Responsible Party):
Bristol-Myers Squibb

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 25, 2025
Estimated Study Completion Date : August 25, 2025